"Innovative fetal intervention may prove to be a game-changer in many cases, but it is too soon to declare its superiority over current conventional strategies for management of hypoplastic left heart syndrome," says Jack Rychik, M.D., director of the Fetal Heart Program at The Children's Hospital of Philadelphia (CHOP).Â